NCT03903926View on ClinicalTrials.gov

Efficacy Trial of a Commercial EV71 Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

15,500

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

October 30, 2020

Conditions
Hand, Foot and Mouth Disease
Interventions
BIOLOGICAL

5000 volunteers (6-35 months)-EV71 vaccine

two doses EV71 vaccines will be administrated on day 0, 30 respectively

Trial Locations (2)

433000

Xiantao Center for Disease Control and Prevention, Xiantao

434200

Songzi Center for Disease Control and Prevention, Jingzhou

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT03903926 - Efficacy Trial of a Commercial EV71 Vaccine | Biotech Hunter | Biotech Hunter